Publications by authors named "Alberto Marangoni"
Article Synopsis
- - This study evaluated the long-term effectiveness of liraglutide for type 2 diabetes over 5 years, focusing on its impact on metabolic parameters and cardiovascular risk.
- - In the study involving 103 patients, significant improvements were observed in HbA1c, fasting plasma glucose, body weight, blood pressure, and lipid profiles, with more patients achieving target HbA1c levels.
- - The findings indicated that while liraglutide reduced the risk of coronary heart disease, it did not significantly affect stroke risk, suggesting that its cardiovascular benefits are specific to heart-related outcomes.
Purpose: Treatment with liraglutide in randomized controlled trials is associated with significant reductions in glycated hemoglobin (HbA1c) and weight loss in type 2 diabetes patients. The aim of this retrospective observational study was to investigate correlations of glycemic control and weight outcomes with baseline characteristics of patients starting liraglutide in outpatient clinics in Italy.
Methods: Type 2 diabetes patients were followed from baseline to 4, 8, and 12 months.
[Choledochal cyst IV A type with primary ductal stricture].
Acta Gastroenterol Latinoam
September 2009
Type IV A choledochal cyst is a very uncommon disease, characterized by congenital cystic dilatation of the biliary tree extending to the intrahepatic biliary channels also. A case of a 19-year-old female with jaundice and abdominal pain is reported. The patient underwent a thorough clinical, laboratory and imaging examination.
View Article and Find Full Text PDF